In this early observational study, we grafted bioengineered corneal implants made from recombinant human collagen and synthetic phosphorylcholine polymer into three patients for whom donor cornea transplantation carried a high risk of transplant failure.
After kidney transplantation, the humoral response was generally detected before transplant failure [7], suggesting that HLA antibodies could be responsible for transplant dysfunction.
In total, there were 51 933 person years (mean 6.9) during periods of transplantation and 7104 person years (mean 3.9) during dialysis after transplant failure.
However, significant risks are associated with stem cell therapy, including increased susceptibility to infection and possibility of transplant failure or relapse of disease.
However, cardiac transplant is still limited by the availability of donor hearts, and, while antirejection strategies have been generally effective, they may cause complications, such as accelerated atherosclerosis and changes in cardiac cells, that ultimately result in transplant failure.
Accurate prediction of kidney transplant failure remains imperfect.
Postrenal reasons of renal transplant failure can be assessed by magnetic resonance urography.
Little is known about vascular access in patients starting hemodialysis therapy after kidney transplant failure.
The major complications are periosteal hypertrophy, delamination of the transplant, arthrofibrosis and transplant failure.
However, risks of complications including tissue ischemia, rejection, and transplant failure are significant.
Renal transplant failure has a devastating impact on patients and their families.
